Piramal Pharma Statistics
Total Valuation
Piramal Pharma has a market cap or net worth of INR 300.03 billion. The enterprise value is 342.12 billion.
Market Cap | 300.03B |
Enterprise Value | 342.12B |
Important Dates
The next estimated earnings date is Friday, October 25, 2024.
Earnings Date | Oct 25, 2024 |
Ex-Dividend Date | Jul 12, 2024 |
Share Statistics
Piramal Pharma has 1.33 billion shares outstanding. The number of shares has increased by 10.02% in one year.
Shares Outstanding | 1.33B |
Shares Change (YoY) | +10.02% |
Shares Change (QoQ) | +0.59% |
Owned by Insiders (%) | 0.20% |
Owned by Institutions (%) | 27.16% |
Float | 607.58M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 93.64 |
PS Ratio | 3.53 |
PB Ratio | 3.78 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 1,232.41 |
EV / Sales | 4.09 |
EV / EBITDA | 25.91 |
EV / EBIT | 58.10 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 59.54 |
Debt / EBITDA | 3.76 |
Debt / FCF | n/a |
Interest Coverage | 1.20 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | 2.60% |
Revenue Per Employee | 12.46M |
Profits Per Employee | 41,316 |
Employee Count | 6,719 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +118.24% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +118.24% |
50-Day Moving Average | 173.51 |
200-Day Moving Average | 147.05 |
Relative Strength Index (RSI) | 82.99 |
Average Volume (20 Days) | 9,960,887 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Piramal Pharma had revenue of INR 83.73 billion and earned 277.60 million in profits. Earnings per share was 0.21.
Revenue | 83.73B |
Gross Profit | 50.64B |
Operating Income | 5.21B |
Pretax Income | 2.41B |
Net Income | 277.60M |
EBITDA | 12.15B |
EBIT | 5.21B |
Earnings Per Share (EPS) | 0.21 |
Balance Sheet
The company has 5.02 billion in cash and 47.10 billion in debt, giving a net cash position of -42.09 billion or -31.75 per share.
Cash & Cash Equivalents | 5.02B |
Total Debt | 47.10B |
Net Cash | -42.09B |
Net Cash Per Share | -31.75 |
Equity (Book Value) | 79.11B |
Book Value Per Share | 59.80 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 60.48%, with operating and profit margins of 6.23% and 0.33%.
Gross Margin | 60.48% |
Operating Margin | 6.23% |
Pretax Margin | 2.88% |
Profit Margin | 0.33% |
EBITDA Margin | 14.51% |
EBIT Margin | 6.23% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.11, which amounts to a dividend yield of 0.05%.
Dividend Per Share | 0.11 |
Dividend Yield | 0.05% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -10.02% |
Shareholder Yield | -9.97% |
Earnings Yield | 0.09% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |